Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

Prognos Health

MAY 31, 2023

And as these stakeholders are presented with more and more RWE from pharmaceutical manufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

Prognos Health

MAY 31, 2023

And as these stakeholders are presented with more and more RWE from pharmaceutical manufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

PharmaTech

MAY 29, 2023

Do you face challenges when it comes to smaller production quantities, more specialization and many product creations. With the help of agile systems pharmaceutical manufacturers can overcome these challenges just as easy. Flexibility is the answer.

Pharmaceutical manufacturing 40

Pharmaceutical manufacturing Specialization Manufacturing Pharmaceutical 40

European Pharmaceutical Review

JULY 8, 2024

Single- or mono-temperature incubation is not easy to implement, but it offers efficiency and performance advantages and an opportunity to simplify the process in a pharmaceutical microbiology laboratory. Phase 2 included selection of 32 new strains mainly found in the pharmaceutical industry (see Table 2).

Food and Drug Administration 95

Food and Drug Administration Pharmaceutical Pharmaceutical manufacturing Pharma 95

Pharma Marketing Network

JANUARY 18, 2023

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). Bob is currently Sr.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Marketing Networking 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

pharmaphorum

DECEMBER 16, 2022

The UN Special Rapporteur on contemporary forms of racism, E. Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceutical companies selling the treatments and vaccines were agreed under terms of confidentiality.

Distribution 96

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 96

Pharmaceutical Technology

SEPTEMBER 15, 2022

It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region. The post The cluster effect: Connectivity and collaboration in life sciences hubs appeared first on Pharmaceutical Technology.

Medical 52

Medical Healthcare Healthcare Networking 52

Impetus Digital

NOVEMBER 23, 2023

In these online programs, a handful of carefully selected KOLs attending the congress are asked to summarize abstracts that will be of special interest to other healthcare providers from their country/region or specialty.

Education 52

Education Healthcare Provider Physicians Pharma 52

pharmaphorum

OCTOBER 26, 2022

Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An

Patients 96

Patients Pharma Consulting Transportation 96

PM360

AUGUST 26, 2024

When once a small population needed a special status called “rare”, now all diseases will be defined by endotypes and phenotypes – smaller segments of like patients with common molecular characteristics. At the same time, pharmaceutical and biotech companies are also playing their part and are already a step ahead.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52